Cigna Group
Close on Oct 19, 2026
- Market cap
- $78.79B
- P/E (TTM)
- 13.5
- Dividend yield
- 2.02%
About Cigna
Hospital & Medical Service Plans, SIC 6324
The Cigna Group operates as a global healthcare company providing integrated pharmacy, medical, and care management solutions. The enterprise conducts operations through two primary business segments: Evernorth Health Services and Cigna Healthcare. Evernorth delivers pharmacy benefit management, specialty drug dispensing, pharmaceutical distribution to clinics and hospitals, and digital care services. Cigna Healthcare offers medical, dental, and behavioral health plans, along with stop-loss insurance and wellness solutions, through insured and administrative service configurations. Its customer base includes commercial employers, public programs, union plans, third-party administrators, health insurers, and individual consumers.
The enterprise maintains an international presence spanning more than thirty global markets and jurisdictions, serving over 185 million customer relationships worldwide. In the United States, its network encompasses approximately 1.7 million physicians and more than 6,000 healthcare facilities, complemented by 35 licensed specialty pharmacies and specialized pharmaceutical fulfillment centers. Its international health division delivers solutions across specific regions including China, Singapore, Hong Kong, Spain, India, and the Middle East. Delaware serves as the company's legal state of incorporation.
Summary of the business section of Cigna's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Cigna Group
- Founded
- 1981
- Headquarters
- Bloomfield, CT
- Address
- 900 Cottage Grove Road 06002
- Phone
- (860) 226-6000
- Website
- thecignagroup.com
- Employees
- 67,700, Dec 31, 2025
- Industry
- Hospital & Medical Service Plans
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Hartford, Connecticut
Stock & identifiers
- Ticker
- CI
- Exchange
- NYSE
- Shares outstanding
- 264M, Jul 24, 2026
- Public float
- $88.00B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 3-for-1, Jun 5, 2007; 3-for-1, May 18, 1998
- SEC CIK
- 1739940
- CUSIP
- 125523100
- ISIN
- US1255231003
- LEI
- 549300VIWYMSIGT1U456
- EIN
- 82-4991898
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| David Cordani | Chairman & CEO, Director | 658,302 |
| Everett Neville | See Remarks | 5,053 |
| Brian C. Evanko | See Remarks | 67,564 |
| Bryan Holgerson | See Remarks | 7,693 |
| Nicole S. Jones | See Remarks | 27,331 |
| Adam Kautzner | See Remarks | 13,533 |
| Matthew Perlberg | See Remarks | 9,345 |
| Jason D. Sadler | See Remarks | 34,705 |
| Paul A. Sanford | See Remarks | 4,335 |
| Jamie G. Kates | Chief Accounting Officer | 2,368 |
| Durga Prasad Koka | EVP, Global CIO | 6,552 |
| Andrea L. Nelson | EVP, General Counsl & Corp Sec | 3,912 |
| Ann M. Dennison | EVP, CFO | 8,154 |
| David J. Brailer | EVP & Chief Health Officer | 17,525 |
| Noelle K. Eder | See Remarks | 13,590 |
| Eric P. Palmer | See Remarks | 75,295 |
| George Kurian | Director | 4,560 |
| Eric C. Wiseman | Director | 23,940 |
| Eric J. Foss | Director | 36,696 |
| Donna F. Zarcone | Director | 27,517 |
| Neesha Hathi | Director | 4,151 |
| Michael J. Hennigan | Director | 1,350 |
| Mark B. McClellan | Director | 6,891 |
| Kimberly A. Ross | Director | 5,294 |
| Kathleen M. Mazzarella | Director | 6,891 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 David M. Cordani | $22.87M | $14.59M | $6.86M | $145 | $148 |
| FY2024 David M. Cordani | $23.25M | $18.91M | $8.07M | $142 | $129 |
| FY2023 David M. Cordani | $21.05M | $8.07M | $6.80M | $152 | $126 |
| FY2022 David M. Cordani | $20.97M | $57.39M | $6.35M | $165 | $124 |
| FY2021 David M. Cordani | $19.87M | $15.45M | $7.16M | $112 | $126 |
| FY2020 David M. Cordani | $19.93M | $15.68M | $7.08M | $102 | $113 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of the end of 2025, The Cigna Group employed approximately 67,700 employees worldwide, with about 88% of our employees based in the United States.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Feb 9, 2023 | Name change | Name changed from Cigna Corp to Cigna Group |
| May 28, 2020 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Jun 21, 2019 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Feb 1, 2019 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Dec 20, 2018 | Name change | Name changed from Halfmoon Parent, Inc. to Cigna Corp |
| May 16, 2018 | Merger | Registration of securities for a merger or exchange offer (S-4) |